Literature DB >> 32206913

[Retinoblastoma].

N Bornfeld1, D Lohmann2, N E Bechrakis3, E Biewald3.   

Abstract

Retinoblastomas represent 6% of all malignant tumors in children under 5 years old, which untreated lead to blindness in the affected eye and death due to metastases. The main symptoms are leukocoria and strabismus, which if possible, always necessitate a clarification within 1 week for exclusion of a retinoblastoma. The most frequent differential diagnoses are Coats' disease and persistent fetal vasculature (PFV) as well as other intraocular tumors, in particular astrocytomas. Systemic chemotherapy, if necessary in combination with laser hyperthermia, local chemotherapy and brachytherapy are the most important methods for eye-preserving treatment. Advanced cases mostly necessitate enucleation.

Entities:  

Keywords:  Chemotherapy; Clinical diagnosis; Differential diagnoses; Molecular genetics; Radiotherapy

Mesh:

Year:  2020        PMID: 32206913     DOI: 10.1007/s00347-020-01081-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  47 in total

1.  Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.

Authors:  Roshan V Sethi; Helen A Shih; Beow Y Yeap; Kent W Mouw; Robert Petersen; David Y Kim; John E Munzenrider; Eric Grabowski; Carlos Rodriguez-Galindo; Torunn I Yock; Nancy J Tarbell; Karen J Marcus; Shizuo Mukai; Shannon M MacDonald
Journal:  Cancer       Date:  2013-10-02       Impact factor: 6.860

2.  Beta-ray brachytherapy with 106Ru plaques for retinoblastoma.

Authors:  Andreas O Schueler; Dirk Flühs; Gerassimos Anastassiou; Christine Jurklies; Markus Neuhäuser; Harald Schilling; Norbert Bornfeld; Wolfgang Sauerwein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-06       Impact factor: 7.038

3.  Episcleral brachytherapy for retinoblastoma.

Authors:  Jose J Echegaray; Yahya A Al-Zahrani; Arun Singh
Journal:  Br J Ophthalmol       Date:  2019-05-23       Impact factor: 4.638

4.  Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.

Authors:  Carlos Bianciotto; Carol L Shields; Juan C Iturralde; Ahmet Sarici; Pascal Jabbour; Jerry A Shields
Journal:  Ophthalmology       Date:  2011-12-02       Impact factor: 12.079

5.  Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy.

Authors:  Jasmine H Francis; David H Abramson; Xunda Ji; Carol L Shields; Luiz F Teixeira; Amy C Schefler; Nathalie Cassoux; Doris Hadjistilianou; Jesse L Berry; Shahar Frenkel; Francis L Munier
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

6.  Application of fluorescein angiography in retinoblastoma.

Authors:  Y Ohnishi; Y Yamana; M Minei; H Ibayashi
Journal:  Am J Ophthalmol       Date:  1982-05       Impact factor: 5.258

7.  INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.

Authors:  Carol L Shields; Alexzandra M Douglass; Meriem Beggache; Emil Anthony T Say; Jerry A Shields
Journal:  Retina       Date:  2016-06       Impact factor: 4.256

8.  Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 years.

Authors:  Larissa A Habib; Jasmine H Francis; Armida Wm Fabius; Pierre Y Gobin; Ira J Dunkel; David H Abramson
Journal:  Br J Ophthalmol       Date:  2017-06-09       Impact factor: 5.908

9.  Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.

Authors:  Jasmine H Francis; Ariana M Levin; Emily C Zabor; Y Pierre Gobin; David H Abramson
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

10.  Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.

Authors:  Qiuying Chen; Bin Zhang; Yuhao Dong; Xiaokai Mo; Lu Zhang; Wenhui Huang; Hua Jiang; Jiejun Xia; Shuixing Zhang
Journal:  BMC Cancer       Date:  2018-04-27       Impact factor: 4.430

View more
  2 in total

1.  Combination of Brachytherapy and Intravitreal Chemotherapy in the Treatment of Retinoblastoma with Vitreous Seeding.

Authors:  Sabrina Schlüter; Norbert Bornfeld; Elbrus Valiyev; Dirk Flühs; Martin Stuschke; Nikolaos E Bechrakis; Tobias Kiefer; Petra Ketteler; Sophia Göricke; Eva M Biewald
Journal:  Ocul Oncol Pathol       Date:  2021-11-30

2.  Autophagy-related gene 7 deficiency caused by miR-154-5p overexpression suppresses the cell viability and tumorigenesis of retinoblastoma by increasing cell apoptosis.

Authors:  Zhenrong Liu; Yan Huang; Fan Zhang; Huairong Tang; Youjuan Wang
Journal:  Ann Transl Med       Date:  2020-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.